Daniel Cortés

Daniel Cortés

Auto-generated profile, based on publicly available information

Daniel Cortés

The Jackson Laboratory, Bar Harbor, ME 04660, USA

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 August 2017 in Frontiers in Molecular Neuroscience
Verified
Journal Article
Open access
DCDaniel Cortés
Daniel Cortés
OCOscar A. Carballo-Molina
Oscar A. Carballo-Molina
MCMaría José Castellanos-Montiel
María José Castellanos-Montiel
IVIván Velasco
Iván Velasco
Glial cell line-derived neurotrophic factor (GDNF) was first characterized as a survival-promoting factor for dopaminergic neurons. Afterwards, other cells were also discovered to respond to GDNF not only as a survival factor but also as a factor supporting other cellular functions, such as proliferation, differentiation, maturation, neurite outgrowth and other phenomena that have been less studied than survival and are now more extendedly described here in this review. During development, GDNF favors the commitment of neural precursors towards dopaminergic, motor, enteric and adrenal neurons; in addition, it enhances the axonal growth of some of these neurons. GDNF also induces the acquisition of a dopaminergic phenotype by increasing the expression of Tyrosine Hydroxylase, Nurr1 and other proteins that confer this identity and promote further dendritic and electrical maturation. In motor neurons, GDNF not only promotes proliferation and maturation but also participates in regenerating damaged axons and modulates the neuromuscular junction at both presynaptic and postsynaptic levels. Moreover, GDNF modulates the rate of neuroblastoma and glioblastoma cancer cell proliferation. Additionally, the presence or absence of GDNF has been correlated with conditions such as depression, pain, muscular soreness, etc. Although, the precise role of GDNF is unknown, it extends beyond a survival effect. The understanding of the complete range of properties of this trophic molecule will allow us to investigate its broad mechanisms of action to accelerate and/or improve therapies for the aforementioned pathological conditions.

1 May 2006 in American Journal of Physiology-Endocrinology and Metabolism
Verified
Journal Article
Closed access
PDF file
RGRaquel Guinzberg
Raquel Guinzberg
DCDaniel Cortés
Daniel Cortés
ADAntonio Díaz-Cruz
Antonio Díaz-Cruz
HRHector Riveros-Rosas
Hector Riveros-Rosas
RVRafael Villalobos-Molina
Rafael Villalobos-Molina
EPEnrique Piña
Enrique Piña
Inosine, an endogenous nucleoside, has recently been shown to exert potent effects on the immune, neural, and cardiovascular systems. This work addresses modulation of intermediary metabolism by inosine through adenosine receptors (ARs) in isolated rat hepatocytes. We conducted an in silico search in the GenBank and complete genomic sequence databases for additional adenosine/inosine receptors and for a feasible physiological role of inosine in homeostasis. Inosine stimulated glycogenolysis (≈40%, EC504.2 × 10−9M), gluconeogenesis (≈40%, EC507.8 × 10−9M), and ureagenesis (≈130%, EC507.0 × 10−8M) compared with basal values; these effects were blunted by the selective A3AR antagonist 9-chloro-2-(2-furanyl)-5-[(phenylacetyl)amino][1,2,4]-triazolo[1,5- c]quinazoline (MRS 1220) but not by selective A1, A2A, and A2BAR antagonists. In addition, MRS 1220 antagonized inosine-induced transient increase (40%) in cytosolic Ca2+and enhanced (90%) glycogen phosphorylase activity. Inosine-induced Ca2+mobilization was desensitized by adenosine; in a reciprocal manner, inosine desensitized adenosine action. Inosine decreased the cAMP pool in hepatocytes when A1, A2A, and A2BAR were blocked by a mixture of selective antagonists. Inosine-promoted metabolic changes were unrelated to cAMP decrease but were Ca2+dependent because they were absent in hepatocytes incubated in EGTA- or BAPTA-AM-supplemented Ca2+-free medium. After in silico analysis, no additional cognate adenosine/inosine receptors were found in human, mouse, and rat. In both perfused rat liver and isolated hepatocytes, hypoxia/reoxygenation produced an increase in inosine, adenosine, and glucose release; these actions were quantitatively greater in perfused rat liver than in isolated cells. Moreover, all of these effects were impaired by the antagonist MRS 1220. On the basis of results obtained, known higher extracellular inosine levels under ischemic conditions, and inosine’s higher sensitivity for stimulating hepatic gluconeogenesis, it is suggested that, after tissular ischemia, inosine contributes to the maintainence of homeostasis by releasing glucose from the liver through stimulation of A3ARs.

12 September 2016 in Frontiers in Cellular Neuroscience
Verified
Journal Article
Open access
DCDaniel Cortés
Daniel Cortés
YRYolanda Robledo-Arratia
Yolanda Robledo-Arratia
RHRicardo Hernández-Martínez
Ricardo Hernández-Martínez
IEItzel Escobedo-Avila
Itzel Escobedo-Avila
JBJosé Bargas
José Bargas
IVIván Velasco
Iván Velasco
Embryonic stem cells (ESC) are pluripotent and thus can differentiate into every cell type present in the body. Directed differentiation into motor neurons has been described for pluripotent cells. Although neurotrophic factors promote neuronal survival, their role in neuronal commitment is elusive. Here, we developed double-transgenic lines of mouse ESC that constitutively produce Glial cell-derived neurotrophic factor (GDNF) and also contain a GFP reporter, driven by HB9, which is expressed only by postmitotic motor neurons. After lentiviral transduction, ESC lines integrated and expressed the human GDNF gene without altering pluripotency markers before differentiation. Further, GDNF-ESC showed significantly higher spontaneous release of this neurotrophin to the medium, when compared to controls. To study motor neuron induction, control and GDNF cell lines were grown as embryoid bodies and stimulated with retinoic acid and Sonic Hedgehog. In GDNF-overexpressing cells, a significant increase of proliferative Olig2+ precursors, which are specified as spinal motor neurons, was found. Accordingly, GDNF increases the yield of cells with the pan motor neuronal markers HB9, monitored by GFP expression, and Isl1. At terminal differentiation, almost all differentiated neurons express phenotypic markers of motor neurons in GDNF cultures, with lower proportions in control cells. To test if the effects of GDNF were present at early differentiation stages, exogenous recombinant human GDNF was added to control ESC, also resulting in enhanced motor neuron differentiation. This effect was abolished by the co-addition of neutralizing anti-GDNF antibodies, strongly suggesting that differentiating ESC are responsive to GDNF. Using the HB9::GFP reporter, motor neurons were selected for electrophysiological recordings. Motor neurons differentiated from GDNF-ESC, compared to control motor neurons, showed greater electrophysiological maturation, characterized by increased numbers of evoked action potentials, as well as by the appearance of rebound action potentials, sag inward rectification, spike frequency adaptation and spontaneous synaptic potentials. Upon challenge with kainate, GDNF-overexpressing cells are more resistant to excitotoxicity than control motor neurons. Together these data indicate that GDNF promotes proliferation of motor neuron-committed precursors, promotes neuronal differentiation, enhances maturation, and confers neuroprotection. GDNF-expressing ESC can be useful in studies of development and disease.

12 August 2014 in Molecular Brain
Verified
Journal Article
Open access
PDF file
IEItzel Escobedo-Avila
Itzel Escobedo-Avila
FVFernanda Vargas-Romero
Fernanda Vargas-Romero
AMAnayansi Molina-Hernández
Anayansi Molina-Hernández
RLRodrigo López-González
Rodrigo López-González
DCDaniel Cortés
Daniel Cortés
IVIván Velasco
Iván Velasco
Histamine (HA) regulates the sleep-wake cycle, synaptic plasticity and memory in adult mammals. Dopaminergic specification in the embryonic ventral midbrain (VM) coincides with increased HA brain levels. To study the effect of HA receptor stimulation on dopamine neuron generation, we administered HA to dopamine progenitors, both in vitro and in vivo.

9 September 2009 in Autonomic & Autacoid Pharmacology
Verified
Journal Article
Closed access
PDF file
DCD. Cortés
D. Cortés
RGR. Guinzberg
R. Guinzberg
RVR. Villalobos‐Molina
R. Villalobos‐Molina
EPE. Piña
E. Piña

5 April 2024 in Science Advances
Verified
Journal Article
Open access
DCDaniel E. Cortes
Daniel E. Cortes
MEMélanie Escudero
Mélanie Escudero
AKAustin C. Korgan
Austin C. Korgan
AMArojit Mitra
Arojit Mitra
AEAlyssa Edwards
Alyssa Edwards
MPMartin F. Pera
Martin F. Pera
The power and scope of disease modeling can be markedly enhanced through the incorporation of broad genetic diversity. The introduction of pathogenic mutations into a single inbred mouse strain sometimes fails to mimic human disease. We describe a cross-species precision disease modeling platform that exploits mouse genetic diversity to bridge cell-based modeling with whole organism analysis. We developed a universal protocol that permitted robust and reproducible neural differentiation of genetically diverse human and mouse pluripotent stem cell lines and then carried out a proof-of-concept study of the neurodevelopmental gene DYRK1A . Results in vitro reliably predicted the effects of genetic background on Dyrk1a loss-of-function phenotypes in vivo. Transcriptomic comparison of responsive and unresponsive strains identified molecular pathways conferring sensitivity or resilience to Dyrk1a1A loss and highlighted differential messenger RNA isoform usage as an important determinant of response. This cross-species strategy provides a powerful tool in the functional analysis of candidate disease variants identified through human genetic studies.